Lipella Pharmaceuticals Stock (NASDAQ: LIPO) stock price, news, charts, stock research, profile.
Open | $0.725 |
Close | $0.711 |
Volume / Avg. | 4.107K / 59.816K |
Day Range | 0.711 - 0.739 |
52 Wk Range | 0.640 - 2.710 |
Market Cap | $5.205M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 0.78% |
Days to Cover | 1.13 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lipella Pharmaceuticals (NASDAQ: LIPO) through any online brokerage.
Other companies in Lipella Pharmaceuticals’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), NexImmune (NASDAQ:NEXI) and Genprex (NASDAQ:GNPX).
The latest price target for Lipella Pharmaceuticals (NASDAQ: LIPO) was reported by Maxim Group on Tuesday, April 9, 2024. The analyst firm set a price target for 2.00 expecting LIPO to rise to within 12 months (a possible 170.53% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Lipella Pharmaceuticals (NASDAQ: LIPO) is $0.7393 last updated Today at April 26, 2024 at 8:22 AM EDT.
There are no upcoming dividends for Lipella Pharmaceuticals.
Lipella Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Lipella Pharmaceuticals.
Lipella Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.